chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Received my first Pfizer vaccine on 3/19/21. Approximately a week later I woke up with numbness in the right side of my groin. Over the next couple of days the numbness was accompanied by weakness and spread to my right buttocks; my right leg and foot; my left leg and foot; my right cheek and top lip on right side of face. I was advised to go to the ER by my doctor; I went to ER. I was kept overnight for observation and discharged with a diagnosis of a pinched nerve. For the length of the following week the numbness, particularly in my legs and feet, became even more intense and I became unable to drive (because I could not use my feet on the floor pedals)... (see attached)
Inflammation under armpit of left arm and raised horizontal welts day after vaccination given. Dr. referred patient to Urgent Care, lasted 1-2 days.
Sick - nausea, headache, body aches, red arm for 1wk, sore arm, injection site swollen and hard, sweats/chills.
79 year old vaccinated female was admitted for Covid-19 pneumonia. She had underlying COPD which did not help in her recovery. She was seen by cardiology for a fib with RVR. TTE showed normal LVEF. She had recurrent coffee ground emesis but GI did not see the need to perform endoscopy. She was then seen by GS. CT abdomen showed ileus with retroperitoneal mass. She had NGT placed to wall suction. She was treated with Daptomycin for possible VRE UTI. She became unresponsive and unconscious while on NGT. Even after it was removed 2 days ago, she did not regain consciousness. Family requested DNR with comfort care measures yesterday. She passed away today at 1022 hours.
He received first Pfizer vaccine and then developed covid; He received first Pfizer vaccine and then developed covid; This is a spontaneous report received from a contactable consumer (patient wife). A 72-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot Number and Expiration Date: Not reported) via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. It was reported that, the patient received first Pfizer vaccine and then developed COVID on an unspecified date. The outcome of the events was reported as unknown.  Information on the lot/batch number has been requested.
Complained of itching all over.  Rash appearing on face, extremities and body.  Redness around eyes within 10-15 minutes of vaccine administration-gave Benadryl 1 tsp per mouth.
No adverse event experienced by patient. Reporting due to improper spacing between dose 1 and dose 2. Dose 1 was administered on 2/6/2023. Dose 2 was administered on 2/23/2023. This was a spacing of 17 days. Patient has been informed and rescheduled to receive 2nd dose in 28 days from 2/23/2023.
No serious side effects after first dose.  no fever, no tiredness.  minimal site pain, very slight bump at injection site. gone within 24 hours.   Second dose small side effects;  very slight bump at injection site, pain upon firm pressure on 3 inch area surrounding lasting for 38-45 hours . about 21 hours after waking the next morning, had eye pain, dryness, gritty feeling, used eye drops with minimum success on relief. after 25 hours eyes feel hot, apply cool compress to closed eyelids, tried eye drops again, some relief.  27 hours started a small temperature of 99.7 - 100.1 for 2.5-3 hours, laid down to rest,  improved although eyes were still a little irritated, dry, gritty, not hot. went to sleep, no further symptoms.
Four days after injection I developed a large red itchy area on my arm below the injection site. It was concerning enough to check with MD to rule out infection. It took 5 days of Benadryl and hydrocortisone cream to reduce.
This report was received from a health professional on 09 May 2008.  This patient is one of three patients reported as part of a cluster.  A child (exact age not reported) experienced itching and redness at the injection site after receiving an intramuscular injection of DAPTACEL (lot number C2935AA).  No other information was provided.  The other two patients in this cluster are captured in case numbers 2008-01489 and 2008-01491.  Additionally, this health professional reported fever and inconsolable crying following DAPTACEL and ActHIB administration; that event is captured in 2008-01488.
Was not able to breathe; Felt like an elephant was on her chest/Squeezing on chest/Terribly tight; Pain on her side; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Was not able to breathe), CHEST DISCOMFORT (Felt like an elephant was on her chest/Squeezing on chest/Terribly tight) and PAIN (Pain on her side) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016b21a) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, the patient experienced DYSPNOEA (Was not able to breathe), CHEST DISCOMFORT (Felt like an elephant was on her chest/Squeezing on chest/Terribly tight) and PAIN (Pain on her side). At the time of the report, DYSPNOEA (Was not able to breathe), CHEST DISCOMFORT (Felt like an elephant was on her chest/Squeezing on chest/Terribly tight) and PAIN (Pain on her side) outcome was unknown. Unknown    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Apr-2021, Heart rate: 42 (Low) 42.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment reported.   This case was linked to MOD21-079381 (E2B Linked Report).; Sender's Comments:  MOD21-079381:
throbbing knees; This is a spontaneous report from a contactable pharmacist.   A 75-years-old non pregnant female patient received bnt162b2 (BNT162B2), dose 2 intramuscular on 22Feb2021 12:00 (Batch/Lot number was not reported) as DOSE 2, SINGLE for covid-19 immunisation. She received historical vaccine bnt162b2 (BNT162B2), dose 1 intramuscular on 30Jan2021 02:00 PM (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included arthritis from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient experienced throbbing knees leading to joint injury on 23Feb2021 14:00 with outcome of recovered.    Upon follow- up(02Mar2021): This is a follow-up spontaneous report received in response to the mail trail sent regarding the confirmation of below mentioned query. The response included, A case from patient who received COVID-19 vaccine and experienced "throbbing knees". asking to provide the Pfizer receipt date (PRD)? The Pfizer receipt date (PRD) is the calendar day that the first Pfizer colleague or person working on behalf of Pfizer first receives information of an AE. responds to the email earlier today. and believe it was received on 23Febuary,  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Covid19 breakthrough.  1st vaccine received on 04/15/2021.  77 y/o PMHx of DM, HTN, HLD, GERD, Pacemaker, Vascular Dementia, CKD stage 3 presents to the ED with c/o worsening generalized weakness, intermittent confusion, persistent cough, poor po intake x1 week.  Pt was diagnosed with Covid19 2 weeks ago on 01/13/2022.  CXR with possible interstitial infection, room air sat 98% and afebrile.  On Abx.
Pain and stiffness in shoulder joint developed day after injection and has not shown any improvement. No treatment.
pernio-like lesions many months after being vaccinated/COVID Toes; This is a literature report.  A 56-year-old female patient received BNT162b2 (BNT162B2), as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "tobacco use disorder" (unspecified if ongoing); "hyperlipidemia" (unspecified if ongoing); "myocardial infarction" (unspecified if ongoing); "coronary artery disease" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), for covid-19 immunisation. The following information was reported: CHILLBLAINS (medically significant), outcome "recovered", described as "pernio-like lesions many months after being vaccinated/COVID Toes". The patient underwent the following laboratory tests and procedures: Ankle brachial index: normal, notes: Resting; normal, notes: exercise; Antineutrophil cytoplasmic antibody: negative; negative; Antinuclear antibody: negative; Auscultation: lungs were clear; unremarkable; Blood test: There was neither anemia nor leukocytosis; C-reactive protein: 21.4 mg/l, notes: Elevated; Heart rate: normal, notes: of the upper and lower extremities with absence of truncal rash, live doreticularis, and vesicular lesions; HLA marker study: negative; negative; heart tones: normal, notes: without murmurs, gallop rhythm, or rubs; unremarkable; physical examination: normal; Red blood cell sedimentation rate: negative; SARS-CoV-2 antibody test: 612.5, notes: elevated Unit- AU/ml; Vital signs measurement: normal. Therapeutic measures were taken as a result of chillblains.  Case report: The development of acral skin lesions resembling pernio was one example and was dubbed COVID toes in this patient population. The case of a COVID-19-vaccinated patient with a likely case of COVID-19 who developed pernio-like skin lesions that resolved after treatment with cilostazol. COVID-19, caused by the severe acute respiratory syndrome coronavirus2(SARS-CoV-2),has been associated with certain dermatologic manifestations. The development of acral skin lesions resembling pernio is one example,  and is dubbed COVID toes''in this patient population. We report the case of a COVID-19-vaccinated patient with a likely case of COVID-19 who developed pernio-like skin lesions that resolved after treatment with cilostazol.; Sender's Comments: Based on available information causal association between the reported event Chillblains cannot be totally excluded, the case will be reassessed once new information becomes available.   The impact of this report on the benefit/risk profile of the Pfizer drug is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-202300148229 Same article/patient/drug and different event;
Immunization site swelled up and was warm to touch per customer. She applied cold compress and used ALEVE and the following day the customer said warmth was gone and swelling decreased.
Patient received Pfizer COVID vaccine.  Per protocol, sat in chair outside pharmacy for 15 minutes.  Upon being asked by the technician if he felt dizzy or funny at all, the patient responded no and the tech informed him he was free to go.  A few minutes later, around noon, as he was walking in the OTC area, the patient fell in a prone position and said he was dizzy and fell.  He was conscious and coherent the entire time.  We took his blood pressure and blood sugar readings after the patient was moved to a bench in a seated position and the readings were normal.  Patient stated he did not want us to call anyone to drive him home.
Pt presented on 8/13/00 with parents, with a rash. Treated with Benadryl Elixir.
Bells Palsy; Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. The patient's historical condition, concomitant medications and drug reactions or allergies were not reported.  On 11-DEC-2017, the patient was vaccinated with zoster vaccine live(ZOSTAVAX) for the long-term prevention of shingles and zoster-related conditions (dose, frequency, route, lot # and expiration date were not reported).        On an unknown date, the patient was treated by a healthcare provider for Bells Palsy. The outcome of event was unknown. As a direct and proximate result of Plaintiff's use of the zoster vaccine live (ZOSTAVAX) vaccine, plaintiff has and will continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and would continue to suffer such losses, and damaged in the future. The reporter considered the event to be related to Zoster Vaccine Live(ZOSTAVAX).  Upon internal review, the event of Bells Palsy was determined to be medically significant.
Some chests pain. I had a headache.  I went doctor, thought it was a chest inflammation.  He did an EKG that came back negative.  He did some muscle movements in chest. He also stated if I had any tingling in my arm to get to the ER.  He also did some blood work. He did give me a presentation to take.
RIGHT NOSTRIL BLEED; FLU LIKE SYMPTOMS; ON THE WAY TO FAINTING; SERUM FELT LIKE FIRE; DIZZINESS; HAVE NOT FELT LIKE MYSELF; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's concurrent conditions included thyroid disorder, and other pre-existing medical conditions included take a thyroid pill daily. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 06-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On APR-2021, the subject experienced have not felt like myself. On 06-APR-2021, the subject experienced on the way to fainting. On 06-APR-2021, the subject experienced serum felt like fire. On 06-APR-2021, the subject experienced dizziness. On 09-APR-2021, the subject experienced flu like symptoms. On 12-APR-2021, the subject experienced right nostril bleed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from on the way to fainting on 06-APR-2021, had not recovered from dizziness, and the outcome of right nostril bleed, serum felt like fire, flu like symptoms and have not felt like myself was not reported. This report was non-serious.; Sender's Comments: V0:Medical assessment comment not required as per standard operating procedures, as the case was assessed as non-serious.
noticed red rash, like hives, approximately 2-3" below injection site. Was red and warm to the touch. Redness spread over whole arm during the following 3 days. No trouble breathing or swallowing
Redness, swelling, increased warmth left upper arm. Patient reports pain occurred soon after receiving the injection and has progressively became worse.
A HBP was transferred onto the line by a Merck account representative to report a temperature excursion.; no additional adverse events were reported; This spontaneous report has been received from a healthcare business professional, referring to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, concurrent condition and concomitant medication was not provided.  On an unknown date, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) (lot # W039294 with expiration date: 11-DEC-2024; route, dose and strength were unknown) for prophylaxis (product storage error). The reporter was unable to provide a date of administration. The reporter said no additional adverse events were reported.   Administered dose of varicella virus vaccine live (oka/merck) (VARIVAX) experienced the temperature excursion below17.4 Fahrenheit degrees (F) for 2 hours 0 minutes 0 seconds. No previous temperature excursions reported.
PT WAS SITTING IN 15 MINUTE OBSERVATION AREA FOLLOWING HER VACCINATION AND BEGAN TO HAVE A "TINT TASTE" TO HER TONGUE. PT STATES SHE NORMAL TAKE CETIRIZINE 10 MG AT HOME PO DAILY HOWEVER DID NOT TAKE IT TODAY. HAS HAD ALLERGIES TO OTHER MEDICATIONS LISTED ABOVE WHERE HAD TO BE GIVEN SOMETHING. PT WAS GIVEN A DOSE OF CETIRIZINE 10 MG PO. PATIENT WAS OBSERVED UNTIL FULL RECOVERY OCCURRED 45 MINUTES LATER
Had funny feeling in throat and chest few minutes after vaccine felt like increased secretions in throat and lungs.  had same type of reaction to first few allergy shots.  took Benadryl and that improved.  had rash on abdomen, back and upper thighs few hours later.  headache and nausea within 2-3 hours and felt fatigued ran low grade fever . next day arm sore and was little chilled/sweaty at times and more easily fatigued.
Patient started complains of difficulty swallowing that felt similar to a ct contrast allergic reaction Stated it felt like a mild reaction Patient refused medical transport and signed AMA form Husband will come to pick up patient
Within an hour of injection, pt experienced N/V, palpitations, dizzeness and abd cramping
Sever body aches, extreme fatigue, headache, chills, fever,  Tylenol made no difference.
Began with cramping, pains, and prickling in left leg and foot 4 days after receiving vaccine. That was followed by pain all over (possibly lymph), sore eyes, sinus pain, stomach burning, migraine with numbness on one side, neck and chest pain and burning began 10 days after vax followed by painful/swollen tongue that turned numb and tingly, buzzing throughout body.  Day 11 after vax I?m coming down with tingling and numbness in jaw and head and a pinny feeling in parts of head followed by numbness in throat, zapping up the neck, prickling pain when I pee. At Day 11 mucus is flowing down my throat. Chest and neck hurt at 12 days after start of symptoms. Body overcome by numbness, tingling, burning, and pain. Chest pain and palpitations cause me to seek emergency care the morning of May 7 and am referred to neurologist. Later that day I have uncontrollable shakes, burning in back of head that started in back and then spread to front and then turned to numbness, numbness/tingling spread to face, neck, chest, arms, and legs, pain in joints, swelling nose. May 8 I have bleeding gums, clumsy walking, burning sensations in face and chest, neck, and knees, followed by heart pain and intense heart palpitations that feel like my heart is clenched in a fist and isn?t being let go and uncontrollable shaking. Went to ER in ambulance. Have not felt symptoms since being treated with Prednisone, Famatodine, Benydryl, and Valium. Still some residual pain however. Other notable symptoms: water tasting sweet and metallic taste in mouth.
Day after receiving vaccination had sore arm and slight fever and headache and assumed just feeling side effects of vaccine. By day 1 after vaccine, fever more persistent and developed a cough and congestion, chills and high fever at night, day 2 sore arm virtually gone but coughing, fever, chills, headache, and now wheezing persisted. Now is day 3 and fever is worsening, eyes warm and hurt to move, headache and congestion affecting whole head, wheezing, coughing, loss of appetite, diarrhea, fatigue, muscle aches all over body despite soreness from vaccine gone, and shortness of breathe.
Neuropathy - numbness and nerve pain in face, feet, hands.  Apparent autoimmune is being treated by supplements.  Some slow recovery in feeling.
Pt experienced sweating and mild dizziness after the flu shot.  Pt  laid down of the flood for 5 to 10 minutes to rest. She recovered after  resting for 5 to 10 minutes
25 hours after receiving the vaccine I developed a stomach ache.  I had stomach cramps and felt nauseous.  I didn't experience any diarrhea or vomiting that night.  The stomach cramps were enough to keep me up for most of the night, but not as bad as food poisoning.  The next morning when I got out of bed I immediately got sick and vomited.  I was very shaky and light headed.  These symptoms continued until about 7 pm on the 30th.
covered in hives; having an allergic reaction; my chest is hurting; my rib are hurting; This is a spontaneous report from a contactable consumer (patient)   A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 04Nov2021 (Batch/Lot number was not reported) as (dose # unknown) single dose for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported.  The patient experienced covered in hives on Nov2021, my chest is hurting on Nov2021, having an allergic reaction on Nov2021, my rib are hurting on Nov2021. The events outcome was unknown.   Additional Context: Concern: Consumer stated, "I got the Pfizer vaccine two days ago and I didn't recognize any of the ingredients as in allergy but to be honest with you I don't know those big words. So and now I am covered in hives and as long as I take Benadryl (treatment) they seem to go away but I am not really sure if maybe I should go to a doctor if this is normal like this is a common symptoms maybe I am having an allergic reaction and my chest is hurting and my rib are hurting but I know that can be a side effect. I just want to make sure if I need to go to the hospital like if I should go or this is this can be normal a side effect with the vaccine." When requested to probe further: Consumer stated, "I am okay. I am trying to figure out if I should go to the emergency room. So, I am kind of in a rush." Consumer was unwilling to complete the report. Further probing could not be done. Hence, limited Information available over the call.  The lot number for BNT162b2 was not provided and will be requested during follow up.
No adverse effects; a patient was administered an improperly stored PEDVAXHIB; This spontaneous report was received from a registered nurse referring to a patient of unknown age and gender. No information was provided regarding the patient's medical history, concurrent conditions, concomitant medications, drug reactions and allergies.  On 15-OCT-2019, the patient was administered an improperly stored haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) with lot number S000354 and expiration date on 18-OCT-2021, for prophylaxis (dose, dose number, route of administration and anatomical injection site were not reported).  It was reported that on an unknown date, the vaccine was exposed to a temperature excursion below 36 Fahrenheit (F) degrees/ 2 Celsius (C) degrees (34.5 F degrees) for 22 minutes and 30 seconds; and above 47 F degrees/ 9 C degrees (48.2 F degrees) for 10 hours and 45 minutes. There were no previous temperature excursions. No adverse effects were reported.